Irritable Bowel Syndrome and Gastrointestinal Dysbiosis Diagnosis and Treatment: An Integrative Review
Identification: MSNJ2211
Issue: May-June 2022
Volume: Vol. 31/No. 3
Credits (Post Test and/or Evaluation Required)
Available until 06/30/2024
- 1.30 - CH
Description
Learning Outcome:
After completing this education activity, the learner will be able to discuss the efficacy of probiotic therapy as a nonpharmacologic treatment option for treating IBS symptoms and improving patient QOL, in comparison to a placebo or popular medications.
Contact hours available until 6/30/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers, authors):
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.
Commercial Support:
No commercial support or sponsorship declared.
Accreditation Statement:
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.
Author(s):
- Ashlyn H. Swintek, BSN, RN, CCRN
- Vickie M. Lester, MSN, RN, CNE
Credits Available
- 1.30 - CH
You must be logged in and own this product in order to post comments.
Shannon Fitzgerald
8/26/22 12:23 am
I think it is actually exciting to know that the bacteria of the IBS gut differs from that of a healthy gut. I guess this is only helpful to the extent that the information is used appropriately. I mainstream medicine I have literally only given probiotics one time in an inpatient setting.
Lucille Carmeli Lorea
9/2/22 4:42 pm
informative
Moira Howell
9/2/22 8:00 pm
Very interesting article. I will be sharing this information with my teammates. I will also encourage others to consult their doctor about alternative therapies to IBS.
Benjamin Soriano
9/29/22 12:04 pm
Great article
Tamera Hussey
11/13/22 7:50 pm
Informative. I work on a medical surgical unit, I often wonder why physicians don't order more probiotics with the amount of antibiotics ordered .Especially when hospital acquired c-diff is a harmful event.
Danielle Joslin
3/11/23 7:52 am
I like the idea of not having to use pharmaceuticals.
Maria Libano
6/9/23 4:18 pm
Important information.
Sandra Slonosky
8/22/22 10:53 am
very informative, especially the use of probiotic instead of pharmaceuticals